vs
Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and SCANSOURCE, INC. (SCSC). Click either name above to swap in a different company.
SCANSOURCE, INC. is the larger business by last-quarter revenue ($766.5M vs $487.7M, roughly 1.6× CLOVER HEALTH INVESTMENTS, CORP.). SCANSOURCE, INC. runs the higher net margin — 2.2% vs -10.1%, a 12.3% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 2.5%). SCANSOURCE, INC. produced more free cash flow last quarter ($28.9M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 0.9%).
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.
ScanSource, Inc. is a leading global specialty technology distributor offering a broad portfolio of solutions including point-of-sale systems, barcode scanning tools, cybersecurity products, cloud services and communication solutions. It primarily serves value-added resellers, managed service providers and enterprise clients across North America, Latin America and Europe, covering retail, healthcare, industrial and public sector core segments.
CLOV vs SCSC — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $487.7M | $766.5M |
| Net Profit | $-49.3M | $16.5M |
| Gross Margin | — | 13.4% |
| Operating Margin | -10.1% | 2.3% |
| Net Margin | -10.1% | 2.2% |
| Revenue YoY | 44.7% | 2.5% |
| Net Profit YoY | -123.2% | -3.3% |
| EPS (diluted) | — | $0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $487.7M | $766.5M | ||
| Q3 25 | $496.6M | $739.6M | ||
| Q2 25 | $477.6M | $812.9M | ||
| Q1 25 | $462.3M | $704.8M | ||
| Q4 24 | $337.0M | $747.5M | ||
| Q3 24 | $331.0M | $775.6M | ||
| Q2 24 | $356.3M | $746.1M | ||
| Q1 24 | $346.9M | $752.6M |
| Q4 25 | $-49.3M | $16.5M | ||
| Q3 25 | $-24.4M | $19.9M | ||
| Q2 25 | $-10.6M | $20.1M | ||
| Q1 25 | $-1.3M | $17.4M | ||
| Q4 24 | $-22.1M | $17.1M | ||
| Q3 24 | $-9.2M | $17.0M | ||
| Q2 24 | $7.4M | $16.1M | ||
| Q1 24 | $-19.2M | $12.8M |
| Q4 25 | — | 13.4% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 14.2% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | 24.5% | 13.1% | ||
| Q2 24 | 30.3% | 13.0% | ||
| Q1 24 | 23.6% | 12.6% |
| Q4 25 | -10.1% | 2.3% | ||
| Q3 25 | -4.9% | 3.5% | ||
| Q2 25 | -2.2% | 3.3% | ||
| Q1 25 | -0.3% | 3.2% | ||
| Q4 24 | -6.4% | 2.5% | ||
| Q3 24 | -2.7% | 2.3% | ||
| Q2 24 | 2.0% | 2.9% | ||
| Q1 24 | -6.5% | 2.3% |
| Q4 25 | -10.1% | 2.2% | ||
| Q3 25 | -4.9% | 2.7% | ||
| Q2 25 | -2.2% | 2.5% | ||
| Q1 25 | -0.3% | 2.5% | ||
| Q4 24 | -6.6% | 2.3% | ||
| Q3 24 | -2.8% | 2.2% | ||
| Q2 24 | 2.1% | 2.2% | ||
| Q1 24 | -5.5% | 1.7% |
| Q4 25 | — | $0.75 | ||
| Q3 25 | — | $0.89 | ||
| Q2 25 | — | $0.87 | ||
| Q1 25 | — | $0.74 | ||
| Q4 24 | — | $0.70 | ||
| Q3 24 | — | $0.69 | ||
| Q2 24 | — | $0.66 | ||
| Q1 24 | — | $0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.3M | $83.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $308.7M | $910.9M |
| Total Assets | $541.0M | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $78.3M | $83.5M | ||
| Q3 25 | — | $124.9M | ||
| Q2 25 | — | $126.2M | ||
| Q1 25 | — | $146.3M | ||
| Q4 24 | $194.5M | $110.5M | ||
| Q3 24 | $288.0M | $145.0M | ||
| Q2 24 | $254.8M | $185.5M | ||
| Q1 24 | $208.3M | $159.1M |
| Q4 25 | $308.7M | $910.9M | ||
| Q3 25 | $340.9M | $914.0M | ||
| Q2 25 | $344.2M | $906.4M | ||
| Q1 25 | $336.1M | $901.7M | ||
| Q4 24 | $341.1M | $900.7M | ||
| Q3 24 | $342.2M | $920.9M | ||
| Q2 24 | $324.9M | $924.3M | ||
| Q1 24 | $292.5M | $944.1M |
| Q4 25 | $541.0M | $1.7B | ||
| Q3 25 | $559.7M | $1.7B | ||
| Q2 25 | $575.0M | $1.8B | ||
| Q1 25 | $583.7M | $1.7B | ||
| Q4 24 | $580.7M | $1.7B | ||
| Q3 24 | $653.0M | $1.8B | ||
| Q2 24 | $674.2M | $1.8B | ||
| Q1 24 | $671.8M | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-66.9M | $30.8M |
| Free Cash FlowOCF − Capex | $-69.0M | $28.9M |
| FCF MarginFCF / Revenue | -14.1% | 3.8% |
| Capex IntensityCapex / Revenue | 0.4% | 0.3% |
| Cash ConversionOCF / Net Profit | — | 1.87× |
| TTM Free Cash FlowTrailing 4 quarters | $-69.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-66.9M | $30.8M | ||
| Q3 25 | $12.1M | $23.2M | ||
| Q2 25 | $5.4M | — | ||
| Q1 25 | $-16.3M | $66.1M | ||
| Q4 24 | $34.8M | $-6.2M | ||
| Q3 24 | $50.0M | $44.8M | ||
| Q2 24 | $44.8M | — | ||
| Q1 24 | $25.9M | $160.2M |
| Q4 25 | $-69.0M | $28.9M | ||
| Q3 25 | $11.4M | $20.8M | ||
| Q2 25 | $4.8M | — | ||
| Q1 25 | $-16.5M | $64.6M | ||
| Q4 24 | $33.3M | $-8.2M | ||
| Q3 24 | $49.6M | $42.5M | ||
| Q2 24 | $44.4M | — | ||
| Q1 24 | $25.5M | $157.7M |
| Q4 25 | -14.1% | 3.8% | ||
| Q3 25 | 2.3% | 2.8% | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | -3.6% | 9.2% | ||
| Q4 24 | 9.9% | -1.1% | ||
| Q3 24 | 15.0% | 5.5% | ||
| Q2 24 | 12.5% | — | ||
| Q1 24 | 7.3% | 21.0% |
| Q4 25 | 0.4% | 0.3% | ||
| Q3 25 | 0.1% | 0.3% | ||
| Q2 25 | 0.1% | 0.3% | ||
| Q1 25 | 0.0% | 0.2% | ||
| Q4 24 | 0.5% | 0.3% | ||
| Q3 24 | 0.1% | 0.3% | ||
| Q2 24 | 0.1% | 0.2% | ||
| Q1 24 | 0.1% | 0.3% |
| Q4 25 | — | 1.87× | ||
| Q3 25 | — | 1.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.79× | ||
| Q4 24 | — | -0.36× | ||
| Q3 24 | — | 2.64× | ||
| Q2 24 | 6.04× | — | ||
| Q1 24 | — | 12.51× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLOV
Segment breakdown not available.
SCSC
| Products And Services | $723.4M | 94% |
| Intelisys Advisory | $25.0M | 3% |
| Recurring Revenue | $18.2M | 2% |
